Getting answers on GABAergic neurons

UTSA researchers find breakthrough discovery on brain cortex functionality
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

SAN ANTONIO—A team of researchers from the University of Texas at San Antonio (UTSA) Neurosciences Institute is challenging the long-held belief that the organization of the cortical circuit of GABAergic neurons is exclusively local. The results of their study hold promise for new treatments for patients with epilepsy, post-traumatic stress disorder, schizophrenia and other mental conditions in which GABAergic neurons play a significant role.

In the past, labeling individual neurons allowed researchers to study the neurons that project from the brain’s cortex to the striatum, suggesting that the pathways are exclusively excitatory. For this reason most people assumed that inhibition must occur when excitatory cortical neurons activate intrastriatal inhibition.

UTSA College of Sciences researchers Alice Bertero, Hector Zurita and Marc Normandin and biology associate professor Alfonso Junior Apicella contested this view by providing anatomical and physiological evidence for the existence of long-range parvalbumin-expression neurons from the cortex to the striatum in the brains of mice.

This finding is an essential step toward better understanding the neuronal mechanism of cortical long-range GABAerginc neurons in healthy and diseased brains.

“Daily we are bombarded by multiple auditory stimuli, including various speeches,” states Apicella in the UTSA’s University Communications & Marketing publication. “Particularly, listeners must determine which speech acoustic features are relevant and generalize across irrelevant ones during speech perception.

“We think that the interaction between the cortex and the striatum is fundamental to optimize non-native speech learning in adulthood. Therefore, it is crucial to determine which of the cortical-striatum pathway’s cellular elements are involved in this process.”

The discovery that the striatum receives both excitatory and inhibitory inputs from the cortex suggests that these inputs’ timing and relative strength can modulate the striatum’s activity. This is important because it invites the scientific community to speculate that the long-range parvalbumin-expressing projects could play a role between the auditory cortex and striatum, through gamma oscillation synchronization.

In the original research article published in Neural Circuits last year, researchers commented that previous studies have shown that cortico-striatal pathways link auditory signals to action-selection and reward-learning behavior through excitatory projections. 

Only recently has it been demonstrated that long-range GABAergic cortico-striatal somatostatin-expressing neurons in the auditory cortex project to the dorsal striatum, and functionally inhibit the main projecting neuronal population, the spiny projecting neuron, according to the article. 

Since the late 19th century, the Spanish neuroanatomist Santiago Ramon y Cajal postulated the importance of interneurons in the neocortex, states the article introduction. After observing and studying the neuronal diversity and anatomy in several mammalian species, Cajal concluded that, “the functional excellence of the human brain is intimately linked to the prodigious abundance and unwonted wealth of forms of the so-called neurons with short axon” (i.e., GABAergic interneurons).

Since then, the local connectivity and neuronal computations of GABAergic “interneurons” in the cerebral cortex, which comprise 15 to 20 percent of the whole neuronal population, have been extensively studied. This led to the overall principle that excitation is both local and long-range, while inhibition is described as being exclusively local. The existence of long-range GABAergic neurons in rats, cats and monkey has been proven anatomically since the 1980s. 

However, only recent investigation has been engaged to understand the functional significance of long-range GABAergic neurons and how different subtypes play distinct roles in cortical processing, according to their differences in morphology, electrophysiology, molecular content and synaptic connectivity patterns.

“Evidence from our lab and others showed a direct inhibitory projection from the cortex to the striatuma basal ganglia area that is involved in the movement, reward-learning and action selection behavior, demonstrated that locomotion could be modulated through direct stimulation of long-range GABAergic neuron terminals in the motor striatum,” the researchers state.

They have proposed that future experiments “will provide further insight into the role of the CS-Parv neurons in timing and ratio of excitation and inhibition, two opposing forces in the mammalian cerebral cortex, that can dynamically affect the cortico-striatal dynamic.” 

About the Author

Related Topics

Published In

December 2020/January 2021 issue
Volume 17 - Issue 1 | January 2021

December 2020/January 2021

December 2020/January 2021 issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue